ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 206 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,338,827,000 | -59.3% | 32,331 | -41.4% | 0.02% | -53.5% |
| Q2 2022 | $3,292,039,000 | -8.2% | 55,180 | +11.7% | 0.04% | +4.9% |
| Q1 2022 | $3,585,975,000 | -16.0% | 49,380 | -2.8% | 0.04% | -6.8% |
| Q4 2021 | $4,270,090,000 | -10.8% | 50,780 | -4.3% | 0.04% | -13.7% |
| Q3 2021 | $4,787,286,000 | +3.6% | 53,080 | +9.5% | 0.05% | +10.9% |
| Q2 2021 | $4,622,758,000 | -19.7% | 48,482 | -4.1% | 0.05% | -28.1% |
| Q1 2021 | $5,758,014,000 | -4.3% | 50,571 | +16.3% | 0.06% | -5.9% |
| Q4 2020 | $6,017,690,000 | +87.8% | 43,471 | +11.5% | 0.07% | +58.1% |
| Q3 2020 | $3,204,341,000 | +16.8% | 38,987 | +11.1% | 0.04% | +4.9% |
| Q2 2020 | $2,744,505,000 | – | 35,087 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |